These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26659836)

  • 21. Oncogenic Ras Isoforms Signaling Specificity at the Membrane.
    Nussinov R; Tsai CJ; Jang H
    Cancer Res; 2018 Feb; 78(3):593-602. PubMed ID: 29273632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectin-8 binds to the Farnesylated C-terminus of K-Ras4B and Modifies Ras/ERK Signaling and Migration in Pancreatic and Lung Carcinoma Cells.
    Meinohl C; Barnard SJ; Fritz-Wolf K; Unger M; Porr A; Heipel M; Wirth S; Madlung J; Nordheim A; Menke A; Becker K; Giehl K
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational Modeling Reveals that Signaling Lipids Modulate the Orientation of K-Ras4A at the Membrane Reflecting Protein Topology.
    Li ZL; Buck M
    Structure; 2017 Apr; 25(4):679-689.e2. PubMed ID: 28286004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane-associated Ras dimers are isoform-specific: K-Ras dimers differ from H-Ras dimers.
    Jang H; Muratcioglu S; Gursoy A; Keskin O; Nussinov R
    Biochem J; 2016 Jun; 473(12):1719-32. PubMed ID: 27057007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High affinity for farnesyltransferase and alternative prenylation contribute individually to K-Ras4B resistance to farnesyltransferase inhibitors.
    Fiordalisi JJ; Johnson RL; Weinbaum CA; Sakabe K; Chen Z; Casey PJ; Cox AD
    J Biol Chem; 2003 Oct; 278(43):41718-27. PubMed ID: 12882980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Hypervariable Region of K-Ras4B Governs Molecular Recognition and Function.
    Abdelkarim H; Banerjee A; Grudzien P; Leschinsky N; Abushaer M; Gaponenko V
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
    Oliva JL; Zarich N; Martínez N; Jorge R; Castrillo A; Azañedo M; García-Vargas S; Gutiérrez-Eisman S; Juarranz A; Boscá L; Gutkind JS; Rojas JM
    J Biol Chem; 2004 Aug; 279(32):33480-91. PubMed ID: 15181015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrinsic protein disorder in oncogenic KRAS signaling.
    Nussinov R; Jang H; Tsai CJ; Liao TJ; Li S; Fushman D; Zhang J
    Cell Mol Life Sci; 2017 Sep; 74(17):3245-3261. PubMed ID: 28597297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?
    Nussinov R; Muratcioglu S; Tsai CJ; Jang H; Gursoy A; Keskin O
    Expert Opin Ther Targets; 2016 Jul; 20(7):831-42. PubMed ID: 26873344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitor.
    Lerner EC; Qian Y; Hamilton AD; Sebti SM
    J Biol Chem; 1995 Nov; 270(45):26770-3. PubMed ID: 7592913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane-mediated induction and sorting of K-Ras microdomain signaling platforms.
    Weise K; Kapoor S; Denter C; Nikolaus J; Opitz N; Koch S; Triola G; Herrmann A; Waldmann H; Winter R
    J Am Chem Soc; 2011 Feb; 133(4):880-7. PubMed ID: 21141956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors.
    Whyte DB; Kirschmeier P; Hockenberry TN; Nunez-Oliva I; James L; Catino JJ; Bishop WR; Pai JK
    J Biol Chem; 1997 May; 272(22):14459-64. PubMed ID: 9162087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. K-Ras4B proteins are expressed in the nucleolus: Interaction with nucleolin.
    Birchenall-Roberts MC; Fu T; Kim SG; Huang YK; Dambach M; Resau JH; Ruscetti FW
    Biochem Biophys Res Commun; 2006 Sep; 348(2):540-9. PubMed ID: 16889753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociation of the K-Ras4B/PDEδ complex upon contact with lipid membranes: membrane delivery instead of extraction.
    Weise K; Kapoor S; Werkmüller A; Möbitz S; Zimmermann G; Triola G; Waldmann H; Winter R
    J Am Chem Soc; 2012 Jul; 134(28):11503-10. PubMed ID: 22721555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoform specific gene expression analysis of KRAS in the prognosis of lung adenocarcinoma patients.
    Yang IS; Kim S
    BMC Bioinformatics; 2018 Feb; 19(Suppl 1):40. PubMed ID: 29504894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. H-Ras dynamically interacts with recycling endosomes in CHO-K1 cells: involvement of Rab5 and Rab11 in the trafficking of H-Ras to this pericentriolar endocytic compartment.
    Gomez GA; Daniotti JL
    J Biol Chem; 2005 Oct; 280(41):34997-5010. PubMed ID: 16079139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.
    Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM
    Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic K-Ras Binds to an Anionic Membrane in Two Distinct Orientations: A Molecular Dynamics Analysis.
    Prakash P; Zhou Y; Liang H; Hancock JF; Gorfe AA
    Biophys J; 2016 Mar; 110(5):1125-38. PubMed ID: 26958889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Differentially Expressed K-Ras Transcript Variants in Patients With Leiomyoma.
    Zolfaghari N; Shahbazi S; Torfeh M; Khorasani M; Hashemi M; Mahdian R
    Reprod Sci; 2017 Oct; 24(10):1438-1443. PubMed ID: 28122482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic K-ras segregates at spatially distinct plasma membrane signaling platforms according to its phosphorylation status.
    Barceló C; Paco N; Beckett AJ; Alvarez-Moya B; Garrido E; Gelabert M; Tebar F; Jaumot M; Prior I; Agell N
    J Cell Sci; 2013 Oct; 126(Pt 20):4553-9. PubMed ID: 23943869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.